BSJ-4-116 is a potent and selective CDK12-targeting PROTAC degrader with 6 nM IC50. It disrupts DNA damage response gene transcription via premature termination and increased polyadenylation, applicable for oncology research in both cellular and animal models to study transcription-dependent vulnerabilities.